<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33914346</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-1878</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>BioEssays : news and reviews in molecular, cellular and developmental biology</Title><ISOAbbreviation>Bioessays</ISOAbbreviation></Journal><ArticleTitle>Cancer as a prospective sequela of long COVID-19.</ArticleTitle><Pagination><StartPage>e2000331</StartPage><MedlinePgn>e2000331</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2000331</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/bies.202000331</ELocationID><Abstract><AbstractText>As the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to surge worldwide, our knowledge of coronavirus disease 2019 (COVID-19) is rapidly expanding. Although most COVID-19 patients recover within weeks of symptom onset, some experience lingering symptoms that last for months ("long COVID-19"). Early reports of COVID-19 sequelae, including cardiovascular, pulmonary, and neurological conditions, have raised concerns about the long-term effects of COVID-19, especially in hard-hit communities. It is becoming increasingly evident that cancer patients are more susceptible to SARS-CoV-2 infection and are at a higher risk of severe COVID-19 than the general population. Nevertheless, whether long COVID-19 increases the risk of cancer in those with no prior malignancies, remains unclear. Given, the disproportionate impact of the disease on the African American community, yet another unanswered question is whether racial disparities are to be expected in COVID-19 sequelae. Herein, we propose that long COVID-19 may predispose recovered patients to cancer development and accelerate cancer progression. This hypothesis is based on growing evidence of the ability of SARS-CoV-2 to modulate oncogenic pathways, promote chronic low-grade inflammation, and cause tissue damage. Comprehensive studies are urgently required to elucidate the effects of long COVID-19 on cancer susceptibility.</AbstractText><CopyrightInformation>&#xa9; 2021 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saini</LastName><ForeName>Geetanjali</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-3502-2491</Identifier><AffiliationInfo><Affiliation>Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aneja</LastName><ForeName>Ritu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 CA239120</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Bioessays</MedlineTA><NlmUniqueID>8510851</NlmUniqueID><ISSNLinking>0265-9247</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001741" MajorTopicYN="N">Black or African American</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054624" MajorTopicYN="N">Health Status Disparities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076782" MajorTopicYN="N">Race Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 sequelae</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">health disparities</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>29</Day><Hour>12</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33914346</ArticleId><ArticleId IdType="pmc">PMC8206711</ArticleId><ArticleId IdType="doi">10.1002/bies.202000331</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Greenhalgh, T. , Knight, M. , A'court, C. , Buxton, M. , &amp; Husain, L. (2020). Management of post&#x2010;acute covid&#x2010;19 in primary care. BMJ (Clinical Research Ed.), 370, m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Honigsbaum, M. , &amp; Krishnan, L. (2020). Taking pandemic sequelae seriously: From the Russian influenza to COVID&#x2010;19 long&#x2010;haulers. Lancet, 396(10260), 1389&#x2013;1391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550169</ArticleId><ArticleId IdType="pubmed">33058777</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec;, A. , Bernabei, R. , &amp; Landi, F. (2020). Persistent symptoms in patients after acute COVID&#x2010;19. JAMA, 324(6), 603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann, V. O. , Carerj, M. L , Wieters, I. , Fahim, M. , Arendt, C. , Hoffmann, J. , Shchendrygina, A. , Escher, F. , Vasa&#x2010;Nicotera, M. , Zeiher, A. M. , Vehreschild, M. , &amp; Nagel, E. (2020). Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID&#x2010;19). JAMA Cardiology, 5(11), 1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, Y.&#x2010;M , Shang, Y.&#x2010;M. , Song, W.&#x2010;B. , Li, Q.&#x2010;Q. , Xie, H. , Xu, Q.&#x2010;F. , Jia, J.&#x2010;L. , Li, L.&#x2010;M. , Mao, H.&#x2010;L. , Zhou, X.&#x2010;M. , Luo, H. , Gao, Y.&#x2010;F. , &amp; Xu, A.&#x2010;G. (2020). Follow&#x2010;up study of the pulmonary function and related physiological characteristics of COVID&#x2010;19 survivors three months after recovery. EClinicalMedicine, 25, 100463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall, M. (2020). The lasting misery of coronavirus long&#x2010;haulers. Nature, 585(7825), 339&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">32929257</ArticleId></ArticleIdList></Reference><Reference><Citation>Fotuhi, M. , Mian, A. , Meysami, S. , &amp; Raji, C. A. (2020). Neurobiology of COVID&#x2010;3. Journal of Alzheimers Disease, 76(1), 3&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7660990</ArticleId><ArticleId IdType="pubmed">32538857</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky, H. , &amp; Patcai, J. (2011). Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post&#x2010;SARS syndrome; a case&#x2010;controlled study. BMC Neurology [Electronic Resource], 11, 37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, P. , Li, J. , Liu, H. , Han, N. , Ju, J. , Kou, Y. , Chen, L. , Jiang, M. , Pan, F. , Zheng, Y. , Gao, Z. , &amp; Jiang, B. (2020). Long&#x2010;term bone and lung consequences associated with hospital&#x2010;acquired severe acute respiratory syndrome: A 15&#x2010;year follow&#x2010;up from a prospective cohort study. Bone Research, 8, 8. Erratum in: Bone Res 2020; 8:34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7018717</ArticleId><ArticleId IdType="pubmed">32128276</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, J. , Wu, J. , Hao, S. , Yang, M. , Lu, X. , Chen, X. , &amp; Li, L. (2017). Long term outcomes in survivors of epidemic Influenza A (H7N9) virus infection. Scientific Reports, 7, 17275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5722861</ArticleId><ArticleId IdType="pubmed">29222500</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay, M. Z. , Poh, C. M. , R&#xe9;nia, L. , Macary, P. A. , &amp; Ng, L. F. P. (2020). The trinity of COVID&#x2010;19: immunity, inflammation and intervention. Nature Reviews Immunology, 20, 363&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari, P. , Rothan, H. A. , Natekar, J. P. , Stone, S. , Pathak, H. , Strate, P. G. , Arora, K. , Brinton, M. A. , &amp; Kumar, M. (2021). Neuroinvasion and encephalitis following intranasal inoculation of SARS&#x2010;CoV&#x2010;2 in K18&#x2010;hACE2 mice. Viruses, 13(1), 132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832889</ArticleId><ArticleId IdType="pubmed">33477869</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg, E. , Podell, K. , Sodickson, D. K. , &amp; Fieremans, E. (2020). The brain after COVID&#x2010;19: Compensatory neurogenesis or persistent neuroinflammation? EClinicalMedicine, 31, 100684.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7773850</ArticleId><ArticleId IdType="pubmed">33409480</ArticleId></ArticleIdList></Reference><Reference><Citation>
Late Sequelae of COVID&#x2010;19. https://stacks.cdc.gov/view/cdc/97200/cdc_97200_DS1.pdf?. Accessed February 26, 2021.</Citation></Reference><Reference><Citation>Rubin, R. (2020). As their numbers grow, COVID&#x2010;19 &#x201c;Long Haulers&#x201d; stump experts. JAMA, 324(14), 1381&#x2013;1383. 10.1001/jama.2020.17709</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17709</ArticleId><ArticleId IdType="pubmed">32965460</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerwyn, M. , &amp; Maes, M. (2017). Mechanisms explaining muscle fatigue and muscle pain in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A review of recent findings. Current Rheumatology Reports, 19(1), 1.</Citation><ArticleIdList><ArticleId IdType="pubmed">28116577</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein&#x2010;Barr, K. J. R. (2019). Virus induced gene&#x2010;2 upregulation identifies a particular subtype of chronic fatigue syndrome/myalgic encephalomyelitis. Frontiers in Pediatrics, 7, 59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6424879</ArticleId><ArticleId IdType="pubmed">30918887</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, C. , &amp; Khanna, R. (2018). Immune&#x2010;based therapeutic approaches to virus&#x2010;associated cancers. Current Opinion in Virology, 32, 24&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">30241042</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle, D. M. , Kim&#x2010;Schulze, S. , Huang, H.&#x2010;H. , Beckmann, N. D. , Nirenberg, S. , Wang, B. , Lavin, Y. , Swartz, T. H. , Madduri, D. , Stock, A. , Marron, T. U. , Xie, H. , Patel, M. , Tuballes, K. , Van Oekelen, O. , Rahman, A. , Kovatch, P. , Aberg, J. A. , Schadt, E. , &#x2026; Gnjatic, S. (2020). An inflammatory cytokine signature predicts COVID&#x2010;19 severity and survival. Nature Medicine, 26(10), 1636&#x2013;1643.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, G. , Fan, Y. , Lai, Y. , Han, T. , Li, Z. , Zhou, P. , Pan, P. , Wang, W. , Hu, D. , Liu, X. , Zhang, Q. , &amp; Wu, J. (2020). Coronavirus infections and immune responses. Journal of Medical Virology, 92(4), 424&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166547</ArticleId><ArticleId IdType="pubmed">31981224</ArticleId></ArticleIdList></Reference><Reference><Citation>Hockel, M. (2001). Biological consequences of tumor hypoxia. Seminars in Oncology, 28(2 Suppl. 8), 36&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">11395851</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaupel, P. , &amp; Harrison, L. (2004). Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. The Oncologist, 9, 4&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15591417</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Tameemi, W. , Dale, T. P. , Al&#x2010;Jumaily, R. M. K. , &amp; Forsyth, N. R. (2019). Hypoxia&#x2010;modified cancer cell metabolism. Frontiers in Cell and Developmental Biology, 7, 4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6362613</ArticleId><ArticleId IdType="pubmed">30761299</ArticleId></ArticleIdList></Reference><Reference><Citation>Muz, B. , De La Puente, P. , Azab, F. , &amp; Azab, A. K. (2015). The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl), 3, 3&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5045092</ArticleId><ArticleId IdType="pubmed">27774485</ArticleId></ArticleIdList></Reference><Reference><Citation>Abassi, Z. , Higazi, A. A. R. , Kinaneh, S. , Armaly, Z. , Skorecki, K. , &amp; Heyman, S. N. (2020). ACE2, COVID&#x2010;19 infection, inflammation, and coagulopathy: Missing pieces in the puzzle. Frontiers in Physiology, 11, 574753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7573220</ArticleId><ArticleId IdType="pubmed">33123031</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary, M. , Bajaj, S. , Bohra, S. , Swastika, N. , &amp; Hande, A. (2015). The domino effect: Role of hypoxia in malignant transformation of oral submucous fibrosis. Journal of Oral and Maxillofacial Pathology: JOMFP, 19(2), 122&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4611916</ArticleId><ArticleId IdType="pubmed">26604484</ArticleId></ArticleIdList></Reference><Reference><Citation>Greten, F. R. , &amp; Grivennikov, S. I. (2019). Inflammation and cancer: Triggers, mechanisms, and consequences. Immunity, 51(1), 27&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6831096</ArticleId><ArticleId IdType="pubmed">31315034</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, W. , Van Gent, D. C. , Incrocci, L. , Van Weerden, W. M. , &amp; Nonnekens, J. (2020). Role of the DNA damage response in prostate cancer formation, progression and treatment. Prostate Cancer and Prostatic Diseases, 23, 24&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8076026</ArticleId><ArticleId IdType="pubmed">31197228</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiwerska, K. , &amp; Szyfter, K. (2019). DNA repair in cancer initiation, progression, and therapy&#x2010;a double&#x2010;edged sword. Journal of Applied Genetics, 60(3&#x2010;4), 329&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6803590</ArticleId><ArticleId IdType="pubmed">31468363</ArticleId></ArticleIdList></Reference><Reference><Citation>

Bernstein, C.
, 
Prasad, A. R.
, 
Nfonsam, V.
, &amp; 
Bernstein, H.
 (2013). DNA damage, DNA repair and cancer. In Chen C. (Ed.), New research directions in DNA repair. IntechOpen. 10.5772/53919. Retrieved from https://www.intechopen.com/books/new-research-directions-in-dna-repair/dna-damage-dna-repair-and-cancer
</Citation><ArticleIdList><ArticleId IdType="doi">10.5772/53919</ArticleId></ArticleIdList></Reference><Reference><Citation>Turgeon, M.&#x2010;O. , Perry, N. J. S. , &amp; Poulogiannis, G. (2018). DNA damage, repair, and cancer metabolism. Frontiers in Oncology, 8, 15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5807667</ArticleId><ArticleId IdType="pubmed">29459886</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokhtari, T. , Hassani, F. , Ghaffari, N. , Ebrahimi, B. , Yarahmadi, A. , &amp; Hassanzadeh, G. (2020). COVID&#x2010;19 and multiorgan failure: A narrative review on potential mechanisms. Journal of Molecular Histology, 51(6), 613&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7533045</ArticleId><ArticleId IdType="pubmed">33011887</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma&#x2010;Lauer, Y. , Carbajo&#x2010;Lozoya, J. , Hein, M. Y. , M&#xfc;ller, M. A. , Deng, W. , Lei, J. , Meyer, B. , Kusov, Y. , Von Brunn, B. , Bairad, D. R. , H&#xfc;nten, S. , Drosten, C. , Hermeking, H. , Leonhardt, H. , Mann, M. , Hilgenfeld, R. , &amp; Von Brunn, A. (2016). p53 down&#x2010;regulates SARS coronavirus replication and is targeted by the SARS&#x2010;unique domain and PLpro via E3 ubiquitin ligase RCHY1. Proceedings of the National Academy of Sciences of the United States of America, 113(35), E5192&#x2013;E5201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5024628</ArticleId><ArticleId IdType="pubmed">27519799</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhardwaj, K. , Liu, P. , Leibowitz, J. L. , &amp; Kao, C. C . (2012). The coronavirus endoribonuclease Nsp15 interacts with retinoblastoma tumor suppressor protein. Journal of Virology, 86(8), 4294&#x2013;4304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3318636</ArticleId><ArticleId IdType="pubmed">22301153</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh, N. , &amp; Bharara Singh, A. (2020). S2 subunit of SARS&#x2010;nCoV&#x2010;2 interacts with tumor suppressor protein p53 and BRCA: An in silico study. Translational Oncology, 13(10), 100814.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7324311</ArticleId><ArticleId IdType="pubmed">32619819</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani, F. , Collavin, L. , &amp; Del Sal, G. (2019). Mutant p53 as a guardian of the cancer cell. Cell Death &amp; Differentiation, 26, 199&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6329812</ArticleId><ArticleId IdType="pubmed">30538286</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozaki, T. , &amp; Nakagawara, A. (2011). Role of p53 in cell death and human cancers. Cancers (Basel), 3(1), 994&#x2013;1013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756401</ArticleId><ArticleId IdType="pubmed">24212651</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorodetska, I. , Kozeretska, I. , &amp; Dubrovska, A. (2019). BRCA genes: The role in genome stability, cancer stemness and therapy resistance. Journal of Cancer, 10(9), 2109&#x2013;2127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548160</ArticleId><ArticleId IdType="pubmed">31205572</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhaddou, M. , Memon, D. , Meyer, B. , White, K. M. , Rezelj, V. V. , Correa Marrero, M. , Polacco, B. J. , Melnyk, J. E. , Ulferts, S. , Kaake, R. M. , Batra, J. , Richards, A. L. , Stevenson, E. , Gordon, D. E. , Rojc, A. , Obernier, K. , Fabius, J. M. , Soucheray, M. , Miorin, L. , &#x2026; Krogan, N. J. (2020). The global phosphorylation landscape of SARS&#x2010;CoV&#x2010;2 infection. Cell, 182(3), 685&#x2013;712.e19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7321036</ArticleId><ArticleId IdType="pubmed">32645325</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason, R. J. (2020). Pathogenesis of COVID&#x2010;19 from a cell biology perspective. European Respiratory Journal, 55(4), 2000607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7144260</ArticleId><ArticleId IdType="pubmed">32269085</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini, G. , Swahn, M. H. , &amp; Aneja, R. (2021). Disentangling the Coronavirus Disease 2019 Health Disparities in African Americans: Biological, Environmental, and Social Factors. Open Forum Infectious Diseases, 8(3), ofab064. 10.1093/ofid/ofab064</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab064</ArticleId><ArticleId IdType="pmc">PMC7928626</ArticleId><ArticleId IdType="pubmed">33732752</ArticleId></ArticleIdList></Reference><Reference><Citation>Ness, R. B. (2004). Differential distribution of allelic variants in cytokine genes among African Americans and White Americans. American Journal of Epidemiology, 160(11), 1033&#x2013;1038.</Citation><ArticleIdList><ArticleId IdType="pubmed">15561982</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xe9;d&#xe9;lec, Y. , Sanz, J. , Baharian, G. , Szpiech, Z. A. , Pacis, A. , Dumaine, A. , Grenier, J.&#x2010;C. , Freiman, A. , Sams, A. J. , Hebert, S. , Pag&#xe9; Sabourin, A. , Luca, F. , Blekhman, R. , Hernandez, R. D. , Pique&#x2010;Regi, R. , Tung, J. , Yotova, V. , &amp; Barreiro, L. B. (2016). Genetic ancestry and natural selection drive population differences in immune responses to pathogens. Cell, 167(3), 657&#x2013;669.e21.</Citation><ArticleIdList><ArticleId IdType="pubmed">27768889</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkworth, J. F. , &amp; Barreiro, L. B. (2014). The contribution of natural selection to present&#x2010;day susceptibility to chronic inflammatory and autoimmune disease. Current Opinion in Immunology, 31, 66&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4344185</ArticleId><ArticleId IdType="pubmed">25458997</ArticleId></ArticleIdList></Reference><Reference><Citation>Pine, S. R. , Mechanic, L. E. , Enewold, L. , Bowman, E. D. , Ryan, B. M. , Cote, M. L. , Wenzlaff, A. S. , Loffredo, C. A. , Olivo&#x2010;Marston, S. , Chaturvedi, A. , Caporaso, N. E. , Schwartz, A. G. , &amp; Harris, C. C. (2016). Differential serum cytokine levels and risk of lung cancer between African and European Americans. Cancer Epidemiology, Biomarkers &amp; Prevention, 25(3), 488&#x2013;497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4779723</ArticleId><ArticleId IdType="pubmed">26711330</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini, G. , Ogden, A. , Mccullough, L. E. , Torres, M. , Rida, P. , &amp; Aneja, R. (2019). Disadvantaged neighborhoods and racial disparity in breast cancer outcomes: The biological link. Cancer Causes &amp; Control, 30(7), 677&#x2013;686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7043809</ArticleId><ArticleId IdType="pubmed">31111277</ArticleId></ArticleIdList></Reference><Reference><Citation>Brody, G. H. , Yu, T. , Miller, G. E. , &amp; Chen, E. (2015). Discrimination, racial identity, and cytokine levels among African&#x2010;American adolescents. Journal of Adolescent Health, 56(5), 496&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4409660</ArticleId><ArticleId IdType="pubmed">25907649</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>